{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_uuid = \"fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9\" and issue_code = \"MMM\" sorted by filing_year descending", "rows": [[3330459, "fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9", "Q1", "AMERICAN SOCIETY OF HEMATOLOGY", 59171, "AMERICAN SOCIETY OF HEMATOLOGY", 2025, "first_quarter", "MMM", "Coverage of blood transfusions under Medicare Hospice Benefit Medicare physician reimbursement issues Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) dental coverage for Medicare beneficiaries National Coverage Decision for hematopoietic stem cell transplantation (HSCT) for MDS Local Coverage Decisions for hematopoietic stem cell transplantation (HSCT) for lymphoma Local Coverage Decisions for next generation sequencing Sickle cell disease quality measures Issues impacting drug shortages Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Impact of proposed Medicaid funding cuts on hematology FY2025 Budget Resolution (H. Con. Res. 14/S. Con. Res. 7) Sickle Cell Disease Comprehensive Care Act (S. 721)", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2025-04-09T13:43:02-04:00"], [3531321, "fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9", "Q1", "AMERICAN SOCIETY OF HEMATOLOGY", 59171, "AMERICAN SOCIETY OF HEMATOLOGY", 2025, "first_quarter", "MMM", "Coverage of blood transfusions under Medicare Hospice Benefit Medicare physician reimbursement issues Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) dental coverage for Medicare beneficiaries National Coverage Decision for hematopoietic stem cell transplantation (HSCT) for MDS Local Coverage Decisions for hematopoietic stem cell transplantation (HSCT) for lymphoma Local Coverage Decisions for next generation sequencing Sickle cell disease quality measures Issues impacting drug shortages Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Impact of proposed Medicaid funding cuts on hematology FY2025 Budget Resolution (H. Con. Res. 14/S. Con. Res. 7) Sickle Cell Disease Comprehensive Care Act (S. 721)", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2025-04-09T13:43:02-04:00"], [3602526, "fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9", "Q1", "AMERICAN SOCIETY OF HEMATOLOGY", 59171, "AMERICAN SOCIETY OF HEMATOLOGY", 2025, "first_quarter", "MMM", "Coverage of blood transfusions under Medicare Hospice Benefit Medicare physician reimbursement issues Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) dental coverage for Medicare beneficiaries National Coverage Decision for hematopoietic stem cell transplantation (HSCT) for MDS Local Coverage Decisions for hematopoietic stem cell transplantation (HSCT) for lymphoma Local Coverage Decisions for next generation sequencing Sickle cell disease quality measures Issues impacting drug shortages Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Impact of proposed Medicaid funding cuts on hematology FY2025 Budget Resolution (H. Con. Res. 14/S. Con. Res. 7) Sickle Cell Disease Comprehensive Care Act (S. 721)", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2025-04-09T13:43:02-04:00"]], "truncated": false, "filtered_table_rows_count": 3, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_uuid\" = :p0 and \"issue_code\" = :p1 order by filing_year desc limit 101", "params": {"p0": "fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9", "p1": "MMM"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9&issue_code=MMM", "results": [{"value": "MMM", "label": "MMM", "count": 3, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9&issue_code=MMM", "results": [{"value": 2025, "label": 2025, "count": 3, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9&issue_code=MMM&filing_year=2025", "selected": false}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9&issue_code=MMM", "results": [{"value": "first_quarter", "label": "first_quarter", "count": 3, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9&issue_code=MMM&filing_period=first_quarter", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9&issue_code=MMM&_facet_date=received_date"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 57.63539299368858, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}